NDC11 63323030351
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63323-0303-51 | 63323-0303 |
| 63323-303-51 | 63323-303 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | 9a5cecd6-aa65-42d2-b15a-06b4fcebcc0f | 2024-02-07 | Boxed warning, Warnings, Adverse reactions | 63323-303 |
| Tobramycin | TOBRAMYCIN SULFATE | Fresenius Kabi USA, LLC | d62ff359-912b-4be1-9fc2-2dde8777eefb | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 63323-303-51 63323-303 63323030351 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.